Molecular aspects of osteoclast function

Inflammation Research

Volumn 45, Issue 1, 1996, Pages 1-9

  Hall, T J ^a   Chambers, T J ^b  

^a CIBA GEIGY LTD   (Switzerland)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Bone resorption; Molecular mechanisms; Osteoclasts; Regulation

Indexed keywords

CALCIUM; CATHEPSIN; COLLAGENASE; INTEGRIN; MEMBRANE RECEPTOR; NITRIC OXIDE; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; REACTIVE OXYGEN METABOLITE;

BONE MINERALIZATION; CALCIUM HOMEOSTASIS; CELL ACTIVITY; CELL PH; CYTOSKELETON; HUMAN; NONHUMAN; ONCOGENE SRC; OSTEOCLAST; OSTEOLYSIS; PROTON SODIUM EXCHANGE; REVIEW; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATASES; ANIMALS; BONE RESORPTION; CATHEPSINS; HUMANS; INTEGRINS; NITRIC OXIDE; OSTEOCLASTS; OSTEOPONTIN; REACTIVE OXYGEN SPECIES; SIALOGLYCOPROTEINS;

EID: 0030068559     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02263497     Document Type: Review

References (115)

1. Marks SC, Popoff SN. Bone cell biology: The regulation of development, structure and function in the skeleton. Am J Anat 1988;183:1-44.
2. Chambers TJ, Hall TJ. Cellular and molecular mechanisms in the regulation and function of osteoclasts. Vitamins and Hormones 1991;46:41-85.
3. Erlebacher A, Filvaroff EH, Gitelman SE, Derynck R. Towards a molecular understanding of skeletal development. Cell 1995;80:371-8.
4. Baron R, Chakraborty M, Chatterjee D, Home W, Lomri A, Ravesloot JH. Biology of the osteoclast. Handbook Exp Pharmacol 1993;107:111-47.
5. Blair HC, Schlesinger PH, Ross FPR, Teitelbaum SL. Recent advances toward understanding osteoclast physiology. Clin Orth Rel Res 1993;294:7-22.
6. Vaananen HK. Mechanism of bone turnover. Ann Med 1993;25:353-9.
7. Rodan GA. Emerging therapies in osteoporosis. Annu Rep Med Chem 1994;29:275-85.
8. [81 Martin TJ, Ng KW. Mechanisms by which cells of the ostcoblast lineage control osteoclast formation and activity. J Cell Biochem 1994;56:357-66.
9. Aubin JE. Osteoclast adhesion and resorption: The role of podosomes. J Bone Min Res 1992;7:365-8.
10. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
11. Davies J, Warwick J, Totty N, Philp R, Helfrich M, Horton M. The osteoclast functional antigen implicated in the regulation of bone resorption is biochemically related to the vitronectin receptor. J Cell Biol 1989;109:1817-26.
12. Robey PG. RGD-containing proteins and bone. Annu Rep Med Chem 1993;28:227-36.
13. Flores ME, Norgard M, Heinegard D, Reinholt FP, Andersson G. RGD-directed attachment of isolated rat osteoclasts to ostcopontin, bone sialoprotein, and fibronectin. Exp Cell Res 1992;201:526-30.
14. 1 integrins. J Biol Chem 1993;268:16737-45.
15. 3 integrin stimulates immediate cell signals in osteoclasts. J Biol Chem 1991;266:20369-74.
16. Shankar G, Davison I, Helfrich MH, Mason WT. Horton MA. Integrin receptor-mediated mobilization of intracellular calcium in rat ostcoclasts. J Cell Sci 1993;105:61-8.
17. Davison I, Shankar G, Horton MA, Mason WT. Integrin-dependent mobilization of intracellular calcium ions in osteoclasts. Ann NY Acad Sci 1994;710:287-300.
18. Hashizume Y, Araki S, Sawada K, Yamada K, Katayama K. Adhesive substrates influence acid-productive activities of cultures rabbit osteoclasts: Cultured osteoclasts with large vacuoles have enhanced acid-productive activities. Exp Cell Res 1995;218:452-9.
19. Reinholt FP, Hultenby K, Oldberg A, Heinegard D. Osteopontin - a possible anchor of osteoclasts to bone. Proc Natl Acad Sci USA 1990;87:4473-5.
20. Arai N, Ohya K, Ogura A. Osteopontin mRNA expression during bone resorption: an in situ hybridization study of induced ectopic bone in the rat. Bone Min 1993;22:129-45.
21. Merry K, Dodds R, Littlewood A, Gowen M. Expression of osteopontin mRNA by osteoclasts and osteoblasts in modeling human bone. J Cell Sci 1993;104:1013-20.
22. Chambers TJ, Fuller K, Darby JA, Pringle JAS, Horton MA. Monoclonal antibodies against osteoclasts inhibit bone resorption in vitro. Bone Min 1986;1:127-35.
23. Sato M, Sardana K, Grasser WA, Garsky VM, Gould RJ. Echistatin is a potent inhibitor of bone resorption in culture. J Cell Biol 1990;115:1179-84.
24. Lakkakorpi PT, Horton MA, Helfrich MH, Karhukorpi EK, Vaananen HK. Vitronectin receptor has a role in bone resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface. J Cell Biol 1991;115:1179-86.
25. 3, in osteoclasts. A study using confocal laser scanning microscopy. J Cell Sci 1993;104:663-70.
26. Richardson A, Parson JT. Signal transduction through integrins: a central role for focal adhesion kinase? Bio Essays 1995;17:229-36.
27. Berry V, Rathod H, Pulman LB, Datta HK. Immunofluorescent evidence for the abundance of focal adhesion kinase in the human and avian osteoclats and its down regulation by calcitonin. J Endocrinol 1994;141:R11-5.
28. Berridge MJ. Inositol trisphosphate and calcium signalling. Nature 1993;361:315-25.
29. Nakamura I, Takahashi N, Sasaki T, Tanaka S, Udagawa N, Murakami H, et al. Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption. FEBS Lett 1995;361:79-84.
30. Hall TJ, Jeker H, Schaueblin M. Wortmannin, a potent inhibitor of phosphatidylinositol 3-kinase, inhibits osteoclastic bone resorption in vitro. Calcif Tiss Int 1995;56:336-38.
31. 3 by ostcopontin stimulates phosphotidylinositol 3-hydroxyl kinase activity. Endocrinol 1995;136:2984-92.
32. 2+]-sensing. J Bone Min Res 1992;7:S111.
33. 0 sensing in cultured osteoclasts. Am J Physiol 1992;263:C130-9.
34. Hruska KA, Chellaiah M, Rolnick F, Yamakawa K, Gupta A. Recent progress in signal transduction related to bone remodeling and aging. Calcif Tiss Int 1995;56 Suppl:S35-8.
35. Chen Q, Kinch MS, Lin TH, Burridge K, Juliano RL. Integrin-mediated cell adhesion activates mitogen-activated protein kinases. J Biol Chem 1994;269:26602-5.
36. Blair HC, Teitelbaum SL, Ghiselli R, Gluck S. Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 1989;245:855-7.
37. Sundquist KT, Lakkakorpi P, Wallmark B, Vaananen HK. Inhibition of osteoclast proton transport by bafilomycin Al abolishes bone resorption. Biochem Biophys Res Comm 1990;168:309-3.
38. + antiporter is the primary proton transport system used by osteoclasts during bone resorption. J Cell Physiol 1990;142:420-4.
39. + exchange and growth factor-induced cytosolic pH changes. Role in cellular proliferation. Biochim Biophys Acta 1989;988:73-97.
40. + exchanger by different types of stimuli. FASEB J 1989;3:2408-14.
41. + antiporter, a glycoprotein of 110kD. Science 1990;247:723-7.
42. +-ATPase antiporter activity is essential for the induction, but not the maintenance of osteoclastic bone resorption and cytoplasmic spreading. Biochem Biophys Res Comm 1992;188:1097-103.
43. +-ATPase type in the ruffled borders of osteoclasts. J Cell Biol 1990;111:1305-11.
44. +-ATPases. Proc Natl Acad Sci USA 1992;89:6257-261.
45. +-ATPase in human osteoclastoma. J Biol Chem 1993;268:7075-80.
46. Mattsson JP, Lorentzon P, Wallmark B, Keeling DJ. Characterization of proton transport in bone-derived membrane vesicles. Biochem Biophys Acta 1993;1146:106-12.
47. +-ATPases. Biochem 1993;32:2808-12.
48. +-ATPase. Bone Min 1994;27:159-66.
49. +-ATPase. J Clin Ivnest 1994;93:2311-8.
50. Hall TJ, Schaueblin M, Chambers TJ. The majority of osteoclasts require mRNA and protein synthesis for bone resorption in vitro. Biochem Biophys Res Comm 1993;195:1245-53.
51. Sasaki T, Ueno-Matsuda E. Cystein-proteinase localization in osteoclasts: An immunochemical study. Cell Tiss Res 1993;271:177-9.
52. Goto T, Kiyoshima T, Moroi R, Tsukuba T, Nishimura Y, Himeno M, et al. Localization of cathepsins B, D, and L in the rat osteoclast by immuno-light and -electron microscopy. Histochem 1994;101:33-40.
53. Rifkin BR, Vernillo AT, Kleckner AP, Auszmann JM, Rosenberg LR, Zimmerman M. Cathepsin B and L activities in isolated osteoclasts. Biochem Biophys Res Comm 1991;179:63-9.
54. Shi GP., Chapman HA, Bhairi SM, DeLeeuw C, Reddy VY, Weiss SJ. Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2. FEBS Lett 1995;357:129-34.
55. Inoaka T, Bilbe G, Ishibashi O, Tezuka KI, Kumegawa M, Kokubo T. Molecular cloning of human cDNA for cathepsin K: Novel cysteine proteinase predominantly expressed in bone. Biochem Biophys Res Comm 1995;206:89-96.
56. Everts V, Delaisse JM, Korper W, Niehof A, Vaes G, Beertsen W. Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases. J Cell Physiol 1992;150:221-31.
57. Chambers TJ, Revell PA, Fuller K, Athanasou NA. Resorption of bone by isolated rabbit osteoclasts, J Cell Sci 1984;66:383-99.
58. Blair HC, Kahn AJ, Crouch EC, Jeffrey JJ, Teitelbaum SL. Isolated osteoclasts resorb the organic and inorganic components of bone. J Cell Biol 1986;102:1164-72.
59. Fuller K, Chambers TJ. Localisation of mRNA for collagenase in osteocytic, bone surface and chondrocytic cells but not osteoclasts. J Cell Sci 1995;108:2221-30.
60. Delaisse JM, Eeckhout Y, Neff L, Francois-Gillet C, Henriet P, Su Y, et al. (Pro)collagenase (matrix metalloproteinase-1) is present in rodent osteoclasts and in the underlying bone-resorbing compartment. J Cell Sci 1993;106:1071-82.
61. Chambers TJ, Fuller K. Bone cells predispose bone surfaces to resorption by isolated rabbit osteoclasts. J Cell Sci 1985;76:155-65.
62. Bolen JB. Nonreceptor tyrosine kinases. Oncogene 1993;8: 2025-31.
63. Taylor SJ, Shalloway D. The cell cycle and c-src. Curr Opinon Genet Develop 1993;3:26-34.
64. Soriano P, Montgomery C, Geske R, Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991;64:693-702.
65. Stem PL, Vogel H, Soriano P. Combined deficiencies of src, fyn, and yes tyrosine kinases in mutant mice. Genes Devel 1994;8:1999-2007.
66. Marks SC, McGuire JL. Primary bone cell dysfunction II-osteopetrosis. In: Tam, CS, Heersche, JNM, Murray, TM, editors Metabolic bone disease: cellular and tissue mechanisms. Boca Raton: CRC Press, 1989:49-61.
67. Felix R, Hofstetter W, Wetterwald A, Cecchini MG, Fleisch HA. Role of CSF-1 in bone metabolism. J Cell Biochem 1994;55:340-9.
68. Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, et al. c-fos: a key regulator of osleoclast-macrophage lineage determination and bone remodeling. Science 1994;266:443-8.
69. Sly WS, Hewett-Emmett D, Whyte MP, Yu YSL, Tashjian RE. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci USA 1983;80:2752-6.
70. Boyce BF, Chen H, Soriano P, Mundy GR, Histomorphometric and immunocytochemical studies of src-related osteopetrosis. Bone 1993;14:335-40.
71. c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 1992;90:1622-7.
72. c-src in association with intracellular membranes. J Cell Biol 1992;119:1003-13.
73. c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo. J Clin Invest 1993;91:2791-5.
74. Hall TJ, Schaueblin M, Missbach M. Evidence that c-src is involved in the process of ostoeclastic bone resorption. Biochem Biophys Res Comm 1994;199:1237-44.
75. Mohn N, Le Cabac V, Fischer S, Maridonneau-Parinin I. The src-family protein-tyrosine kinase p59hck is located on the secretory granules in human neutrophils and translocates towards the phagosome during cell activation. Biochem J 1995;309:657-65.
76. Nemeth EF, Scarpa A. Rapid mobilization of cellular Ca2+ in bovine parathyroid cells evoked by extracellular divalent cations. Evidence for a cell surface calcium receptor. J Biol Chem 1987;262:5188-96.
77. Malgaroli A, Meldolesi J, Zambonin-Zallone A, Teti A. Control of cytosolic free calcium in rat and chicken osteoclasts. The role of extracellular calcium and calcitonin. J Biol Chem 1989;264:14342-7.
78. Zaidi M, Datta HK, Patchell A, Moonga B, MacIntrye I. Calcium-activated intracellular calcium: a novel mechanism of osteoclast regulation. Biochem Biophys Res Comm 1989;163:1461-5.
79. Miyauchi A, Hruska KA, Greenfield EM, Duncan R, Alvaraz J, Barattolo R, et al. Ostoeclast cytosolic calcium, regulated by voltage operated calcium channels and extracellular calcium, controls podosome assembly and hone resorption. J Cell Biol 1990;111:2543-52.
80. Zaidi M, Kerby J, Huang CLH, Alam ASMT, Rathod H, Chambers TJ, et al. Divalent cations mimic the inhibitory effect of extracellular ionised calcium on bone resorption by isolated rat osteoclasts: Further evidence for a "calcium receptor". J Cell Physiol 1991;149:422-7.
81. 2+ sensing by the osteoclast. Cell Calcium 1993;14:271-7.
82. 2+ sensing is modulated by pH in human osteoclast-like cells in vitro. Am J Physiol 1994;267:C961-8.
83. Silver IA, Murrills RJ, Etherington DJ. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 1988;175:266 76.
84. Teti A, Marchisio PC, Zambonin-Zallone A. Clear zone in osteoclast function: role of podosomes in regulation of bone-resorbing activity. Am J Physiol 1991;261:C1-7.
85. 2+, nitric oxide and free radicals. Biosci Rep 1992;12:369-80.
86. Stroop SD, Thompson DL, Kuestner RE, Moore EE. A recombinant human calcitonin receptor functions as an extracellular calcium sensor. J Biol Chem 1993;268:19927-30.
87. Nicholson GC, Moseley JM, Seyton PM, Mendelsohn FAO, Martin TJ. Abundant calcitonin receptors in isolated rat osteoclasts. J Clin Invest 1986;78:355-60.
88. Wucherpfenning AL, Dewhirst FE, Stashenko P. Platelet activating factor increases intracellular calcium in isolated osteoclasts but does not modify bone resorption. Bone 1993;14:13-8.
89. Hall TJ. A reappraisal of the effect of extracellular calcium on osteoclastic bone resorption. Biochem Biophys Res Comm 1994;202:456-62.
90. Teti A, Blair HC, Schlesinger P, Grano M, Zambonin-Zallone A, Kahn AJ, et al. Extracellular protons acidify osteoclasts, reduce cytosolic calcium, and promote expression of cell-matrix attachment structures. J Clin Invest 1989;84:773-80.
91. 2+-sensing receptor from bovine parathyroid. Nature 1993;366:575-80.
92. Schreck R, Baeuerle PA. A role for oxygen radicals as second messengers. Trends Cell Biol 1991;1:39-42.
93. Segal AW, Abo A. The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem Sci 1993;18:43-7.
94. Garrett IR, Boyce BF, Oreffo ROC, Bonewald L, Poser J, Mundy GR. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 1990;85:632-9.
95. Key LL, Wolf WC, Gundberg CM, Ries LL. Superoxide and bone resorption. Bone 1994;15:431-6.
96. Steinbeck MJ, Appel WH, Verhoeven AJ, Karnovsky MJ. NADPH-oxidase expression and in situ production of Superoxide by osteoclasts actively resorbing bone. J Cell Biol 1994;126:765-72.
97. Bax BE, Towhidul ASM, Banerji B, Bax CMR, Bevis PJR, Stevens CR, et al. Stimulation of osteoclastic bone resorption by hydrogen peroxide. Biochem Biophys Res Comm 1992;183:1153-8.
98. Hall TJ, Schaueblin M, Jeker H, Fuller K, Chambers TJ. The role of reactive oxygen intermediates in osteoclastic bone resorption. Biochem Biophys Res Comm 1995;207:280-7.
99. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 2nd ed. Oxford, Clarendon Press, 1993.
100. Dodds RA, Gowen M, Bradbeer JN. Fat: The major energy source of resorbing osteoclasts. J Bone Min Res 1992;7:S312.
101. Liu CC, Rader JI, Gruber H, Baylink DJ. Acute reduction in osetoclast numbers during bone repletion. Metab Bone Dis Rel Res 1982;4:201-9.
102. Kameda T, Ishikawa H, Tsutsui T. Detection and characterization of apoptosis in osteoclasts in vitro. Biochem Biophys Res Comm 1995;207:753-60.
103. Wright KR, Hughes DH, Guise TA, Boyle IT, Devlin R, Windle J, et al. Osteoclasts undergo apoptosis at the interface between resorption and formation in bone remodeling units. J Bone Min Res 1994;9 Suppl:S174.
104. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994;15:7-10.
105. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-64.
106. Moncada S, Higgs A. The L-arginine - nitric oxidde pathway. N Engl J Med 1993;329:2002-12.
107. Nussler AK, Billiar TR. Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leuk Biol 1993;54:171-8.
108. Anggard E. Nitric oxide: mediator, murderer, and medicine. Lancet 1994;343:1199-206.
109. McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie QW, Nathan C, et al. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993;178:749-54.
110. MacIntyre I, Zaidi M, Alam ASMT, Datta HK, Moonga BS, Lidbury PS, et al. Osteoclastic inhibition: An action of nitric oxide not mediated by cyclic GMP. Proc Natl Acad Sci USA 1991;88:2936-40.
111. Damoulis PD, Hauschka PV. Cytokines induce nitric oxide production in mouse osteoblasts. Biochem Biophys Res Comm 1994;201:924-31.
112. Lowik CWGM, Nibbering PH, van de Ruit M, Papapoulos SH. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse explants is associated with suppression of osteoclastic bone resorption. J Clin Invest 1994;93:1465-72.
113. Ralston SH, Todd D, Helfrich M, Benjamin N, Granowski PS. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinol 1994;135:330-6.
114. Kasten TP, Collin-Osdoby P, Patel N, Osdoby P, Krukowski M, Misko TP, et al. Potentiation of osteoclast bone resorption activity by inhibition of nitric oxide synthase. Proc Natl Acad Sci USA 1994;91:3569-73.
115. Brandi ML, Hukkanen M, Umeda T, Moradi-Bidhendi N, Bianchi S, Gross SS, et al. Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms. Proc Natl Acad Sci USA 1995;92:2954-8.